Day: June 11, 2025

U.S. FDA successfully completed Pre-License Inspection; Company expects facility will meet all requirements to support licensure Advisory Committee meeting scheduled for July 30, 2025 Mid-cycle meeting recently completed with no significant issues or major deficiencies; late-cycle meeting planned for mid-July Biologics License Application remains under priority review with PDUFA target action date of August 31, 2025SAN DIEGO, June 11, 2025 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced the successful completion of the U.S. Food and Drug Administration’s (FDA) Pre-License Inspection (PLI) of its San Diego manufacturing facility for Deramiocel, the Company’s lead cell therapy candidate...

Sending a correction due to mistake in the Meeting’s accounting day – 23 June 2025On 1 July 2025, the ordinary general meeting of shareholders (the Meeting) of Public limited liability company “Novaturas”, code 135567698, registered at A. Mickevičiaus str. 27, Kaunas, the Republic of Lithuania (the Company), is being convened upon the initiative and decision of the Board of the Company. The place of the Meeting (address): J. Jasinskio st. 16 C, Vilnius, Lithuania, Conference Centre, hall B. Start of the Meeting: the Meeting starts at 10:00 a.m. (registration of shareholders starts at 9:00 a.m.). The Meeting’s accounting day – 23 June 2025. Only persons who are shareholders of the Company at the end of accounting day of the Meeting or persons authorized by them, or persons with whom shareholders concluded the agreements on...

ROSEVILLE, Minn, June 11, 2025 (GLOBE NEWSWIRE) — – Hawkins, Inc. (Nasdaq: HWKN), a leading water treatment and specialty ingredients company, today announced that it will participate in the CJS Securities 25th Annual New Ideas Summer Conference on July 10, 2025. The conference will be held at the Metropolis Country Club in White Plains, NY. The conference will be attended by a group of targeted institutional investors, where each company in attendance will have a presentation slot and will be available for one-on-one meetings. For more information about this conference or to schedule a meeting with Hawkins management, please contact the event coordinators or Hawkins Investor Relations at ir@hawkinsinc.com. About Hawkins, Inc. Hawkins, Inc. was founded in 1938 and is a leading water treatment and specialty ingredients company...

— Femasys continues to expand access and market share for its first-line infertility treatment option, FemaSeed® — ATLANTA, June 11, 2025 (GLOBE NEWSWIRE) — Femasys, Inc., (Nasdaq: FEMY), a leading biomedical innovator addressing significant unmet needs in women’s health worldwide, with a broad portfolio of disruptive, accessible, in-office therapeutic and diagnostic products announces a partnership with Carolinas Fertility Institute (CFI), one of America’s best fertility clinics. Carolinas Fertility Institute will provide the Company’s FemaSeed® intratubal insemination product as an infertility treatment option to patients throughout its network in North Carolina. “Our partnership with Carolinas Fertility Institute reflects the growing momentum behind FemaSeed as a meaningful first-line fertility solution,” said Kathy...

AppFolio Realm-X Performers enable agentic operations across complex workflows, delivering outcomes and a better experience for residents, property managers, owners, and investorsAppFolio Realm-X Performers enable agentic operations across complex workflows, delivering outcomes and a better experience for residents, property managers, owners, and investorsLAS VEGAS, June 11, 2025 (GLOBE NEWSWIRE) — AppFolio (NASDAQ:APPF), the technology leader powering the future of the real estate industry, announced its latest innovations at NAA Apartmentalize 2025, including the next evolution of AppFolio Realm-X – its embedded generative AI – through the introduction of Realm-X Performers, designed to automate complex workflows through advanced agentic operations. According to the 2025 AppFolio Property Management Benchmark...

BASKING RIDGE, N.J., June 11, 2025 (GLOBE NEWSWIRE) — Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced that David J. Mazzo, Ph.D., President and Chief Executive Officer of Lisata, will present a corporate overview at the upcoming 2025 BIO International Convention taking place in Boston, MA from June 16 – 19, 2025. Dr. Mazzo’s presentation is scheduled for Tuesday, June 17th at 11:15 a.m. Eastern Time in Room 153A. To register for the conference and schedule a one-on-one meeting with Lisata’s management, please visit https://www.bio.org/events/bio-international-convention/registration. About Lisata Therapeutics Lisata Therapeutics is a clinical-stage pharmaceutical...

MIAMI, FL, June 11, 2025 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced the company will be participating in one-on-one meetings and a fire side chat presentation with investors at the virtual BTIG Obesity Health Forum on June 18, 2025. About Veru Inc.Veru is a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases. The Company’s drug development program includes two late-stage novel small molecules, enobosarm and sabizabulin. Enobosarm, a selective androgen receptor modulator (SARM), is being developed as a next generation drug that makes weight reduction by GLP-1 RA...

MONTREAL, June 11, 2025 (GLOBE NEWSWIRE) — DAVIDsTEA Inc. (TSX-Venture: DTEA) (“DAVIDsTEA” or the “Company”), a leading tea merchant in North America, announced today that its financial results for the first quarter of Fiscal 2025 will be released before markets open on June 17, 2025. The Company will host a webcast same day at 8:30 a.m. Eastern Time to discuss the financial results. Details of the webcast Via the internet at: www.davidstea.com, in the “investor” section, or at: https://www.gowebcasting.com/14086 An online archive of the webcast will be available within two hours of the conclusion of the call and will remain available for 30 days. About DAVIDsTEADAVIDsTEA offers a specialty branded selection of high-quality proprietary loose-leaf teas, pre-packaged teas, tea sachets, tea-related accessories and gifts...

Innovative Appliances Designed to Enhance Everyday Living, Expand Retail Reach, and Strengthen Aterian’s Brand Portfolio SUMMIT, N.J., June 11, 2025 (GLOBE NEWSWIRE) — Aterian, Inc. (Nasdaq: ATER), a consumer products company, today announced the national launch of two of its most innovative home appliances – the PurSteam Steam Station Max and the Mueller Living Cordless Portable Vacuum Sealer – now available nationwide across Walmart locations. “These launches reflect Aterian’s broader mission to expand our omni-channel presence by bringing high-quality consumer products to both digital and physical retail platforms,” said Arturo Rodriguez, Chief Executive Officer of Aterian. “The increased brand visibility, coupled with mass-market accessibility, is designed to strengthen the Company’s growth trajectory and retail...

SMARTOX has deployed over 50 of INBS’ Intelligent Fingerprinting Drug Screening Readers and facilitated over 7,000 screening tests, including more than 1,500 tests in 2024 alone Company continues to actively pursue FDA clearance in connection with planned expansion into broader U.S. markets in 2025 NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced an update on its growing footprint in the U.S. Forensic Use Only Market through its strategic partnership with SMARTOX, a Texas-based leader in drug and alcohol screening services. SMARTOX supports clients across corrections, drug courts, rehabilitation centres, and other forensic environments....